Dr  Georgios K Dimitriadis, MD, MSc(Hons), PGDip (Obes), MAcadTM,  SCOPE (Cert.), PhDc - University of Warwick Medical School - University Hospitals Coventry and Warwickshire NHS Trust - Senior Clinical Fellow in Endocrinology, Diabetes and Metabolism - Subspecialist in Reproductive Endocrinology and Metabolic Diseases

Dr Georgios K Dimitriadis

MD, MSc(Hons), PGDip (Obes), MAcadTM, SCOPE (Cert.), PhDc

University of Warwick Medical School - University Hospitals Coventry and Warwickshire NHS Trust

Senior Clinical Fellow in Endocrinology, Diabetes and Metabolism - Subspecialist in Reproductive Endocrinology and Metabolic Diseases

Warwick, West Midlands | United Kingdom

Main Specialties: Endocrinology Diabetes & Metabolism

Additional Specialties: Subspecialist in Reproductive Endocrinology and Metabolic Medicine

ORCID logohttps://orcid.org/0000-0002-6662-804X

Dr  Georgios K Dimitriadis, MD, MSc(Hons), PGDip (Obes), MAcadTM,  SCOPE (Cert.), PhDc - University of Warwick Medical School - University Hospitals Coventry and Warwickshire NHS Trust - Senior Clinical Fellow in Endocrinology, Diabetes and Metabolism - Subspecialist in Reproductive Endocrinology and Metabolic Diseases

Dr Georgios K Dimitriadis

MD, MSc(Hons), PGDip (Obes), MAcadTM, SCOPE (Cert.), PhDc
Introduction

Primary Affiliation: University of Warwick Medical School - University Hospitals Coventry and Warwickshire NHS Trust - Warwick, West Midlands , United Kingdom

Specialties:

Additional Specialties:

Research Interests:

Metrics

26

Publications

1030

Profile Views

203

Reads

25

PubMed Central Citations

Education
Jun 2018
World Obesity Federation
SCOPE (Cert.)
Oct 2017
Karolinska Institutet
PGDip (Obesity)
Sep 2017
European Society of Translational Medicine
MAcadTM
Jan 2017
University of Warwick Medical School/Imperial College London
PhD(candidate)
Sep 2013
National and Kapodistrian University of Athens Medical School
MSc/MRes (Hons)
Nov 2005
National and Kapodistrian University of Athens Medical School
MD
Experience
Oct 2017
European Obesity Academy - Karolinska Institutet
Clinical, Research, Leadership
Apr 2016
UEMS 3E (Expertise in Endocrinology Exchange) Scholarship
Clinical Research
Mar 2016
NovoNordisk UK Research Foundation 2016 PhD Fellowship Finalist
Clinical Research
Jan 2016
"Chancellors" Warwick Medical School Scholarship
Clinical Research
Apr 2014
Post MSc Scholarship from Athens Medical School
Clinical Research
Top co-authors
Harpal S Randeva
Harpal S Randeva

Warwick Medical School

14
Gregory Kaltsas
Gregory Kaltsas

National and Kapodistrian University of Athens

11
Martin O Weickert
Martin O Weickert

Warwickshire Institute for the Study of Diabetes

5
Thomas M Barber
Thomas M Barber

Churchill Hospital

4
Alexander D Miras
Alexander D Miras

Imperial College London

4
Dimitris K Grammatopoulos
Dimitris K Grammatopoulos

Warwick Medical School

3
Ashley Grossman
Ashley Grossman

Churchill Hospital

3
John G Hattersley
John G Hattersley

University Hospitals Coventry and Warwickshire NHS Trust

3
Ioannis Kyrou
Ioannis Kyrou

School of Health Science and Education

3
Christos Kosmas
Christos Kosmas

Metaxa Cancer Hospital

3

Publications

26Publications

203Reads

25PubMed Central Citations

Identification of an optimal threshold for detecting human brown adipose tissue using receiver operating characteristic analysis of IDEAL MRI fat fraction maps.

Magn Reson Imaging 2018 Sep 26;51:61-68. Epub 2018 Apr 26.

University of Warwick, Clinical Sciences Research Laboratories, Clifford Bridge Road, Coventry CV2 2DX, UK; Department of Radiology, University Hospitals Coventry and Warwickshire, Clifford Bridge Road, Coventry CV2 2DX, UK.

View Article
September 2018
6 Reads
2.02 Impact Factor

Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.

Cardiovasc Diabetol 2018 Jul 26;17(1):106. Epub 2018 Jul 26.

Department of Biological Chemistry, National and Kapodistrian University of Athens Medical School, Athens, Greece.

View Article
July 2018
5 Reads
4.01 Impact Factor

Supplementation of Vitamin D Deficiency in Patients with Neuroendocrine Tumors Using Over-the-Counter Vitamin D3 Preparations.

Nutr Cancer 2018 Jul 21;70(5):748-754. Epub 2018 May 21.

a The ARDEN NET Centre, European Neuroendocrine Tumour Society (ENETS) Centre of Excellence (CoE), University Hospitals Coventry and Warwickshire NHS Trust , Coventry , UK.

View Article
July 2018
5 Reads
2.32 Impact Factor

The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome.

Eur J Clin Invest 2018 Jul 13;48(7):e12961. Epub 2018 Jun 13.

Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

View Article
July 2018
14 Reads
2.73 Impact Factor

Effects of visfatin on brown adipose tissue energy regulation using T37i cells.

Cytokine 2018 Jul 27. Epub 2018 Jul 27.

Division of Translational and Experimental Medicine, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK; WISDEM Centre, Human Metabolism Research Unit, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK; Division of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK. Electronic address:

View Article
July 2018
2 Reads
2.66 Impact Factor

Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.

Endocrine 2018 04 2;60(1):175-184. Epub 2018 Feb 2.

Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, Clifford Bridge Road, Coventry, CV2 2DX, UK.

View Article
April 2018
13 Reads
1 PubMed Central Citation(source)
3.53 Impact Factor

Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion.

Oncotarget 2018 Mar 30;9(24):16678-16690. Epub 2018 Mar 30.

Division of Translational and Experimental Medicine, Warwick Medical School, University of Warwick, Coventry, UK.

View Article
March 2018
8 Reads
6.36 Impact Factor

Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines.

Curr Pharm Des 2016 ;22(36):5535-5546

Division of Translational and Experimental Medicine, Warwick Medical School, University of Warwick, Coventry CV4 7AL, United Kingdom.

View Article
December 2017
19 Reads
2 PubMed Central Citations(source)
3.45 Impact Factor

Potential Hormone Mechanisms of Bariatric Surgery.

Curr Obes Rep 2017 Sep;6(3):253-265

Academic Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Campus, London, W12 0NN, UK.

View Article
September 2017
6 Reads
1 PubMed Central Citation(source)

Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET).

Oncotarget 2017 Sep 16;8(44):76961-76973. Epub 2017 Aug 16.

Division of Translational Medicine, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, University Hospital, Coventry, U.K.

View Article
September 2017
15 Reads
6.36 Impact Factor

Hypertestosteronemia and Infertility from a Mediastinal Extragonadal Germ Cell Tumor.

Am J Med 2017 Jun 2;130(6):e261-e263. Epub 2017 Feb 2.

Department of Endocrinology, Diabetes and Metabolism, WISDEM Centre, UHCW NHS Trust, Coventry, United Kingdom; Centre for Reproductive Medicine, UHCW NHS Trust, Coventry, United Kingdom; Division of Translational and Experimental Medicine, University of Warwick Medical School, Coventry, United Kingdom.

View Article
June 2017
9 Reads
5.00 Impact Factor

Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies.

Endocr Relat Cancer 2017 06 11;24(6):R239-R259. Epub 2017 Apr 11.

Department of EndocrinologyOxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK.

View Article
June 2017
2 Reads
1 PubMed Central Citation(source)
4.80 Impact Factor

Paraneoplastic endocrine syndromes.

Endocr Relat Cancer 2017 06 24;24(6):R173-R190. Epub 2017 Mar 24.

Oxford Centre for DiabetesEndocrinology and Metabolism, University of Oxford, Oxford, UK.

View Article
June 2017
3 Reads
1 PubMed Central Citation(source)
4.80 Impact Factor

Microvascular complications after metabolic surgery.

Lancet Diabetes Endocrinol 2017 04 23;5(4):240-241. Epub 2017 Feb 23.

Academic Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Campus, London, UK. Electronic address:

View Article
April 2017
4 Reads

Paraneoplastic syndromes related to neuroendocrine tumours

Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. 2017 Feb 16.

EndoText

Low or high grade malignant neoplasms present syndromes secondary to symptoms related to local mass effects to surrounding structures or through the development of metastases. A significant number of neoplasms, irrespective of their endocrine differentiation, can present with clinical syndromes produced from the secretion of bioactive substances from tumoural cells, although this is more prevalent in neuroendocrine tumours. Occasionally syndromes related to the immune cross-reactivity of tumoural antigens with the normal tissues may also develop. These syndromes are named endocrine paraneoplastic when the specific secretory components (hormones, peptides or cytokines) are unrelated to the anticipated tissue or organ of origin. Endocrine paraneoplastic syndromes can precede, occur concomitantly or present at a later stage of tumour development and may complicate the patient’s clinical course, response to treatment, and impact overall prognosis. Their detection can facilitate the diagnosis of the underlying neoplasia, monitor response to treatment, detect early recurrences and correlate with prognosis. Although when associated with tumours of low malignant potential they usually do not affect long-term outcome, in cases of highly malignant tumours, endocrine paraneoplastic syndromes are usually associated with poorer survival outcomes. Currently, no specific underlying pathogenic mechanism has been identified although a number of plausible hypotheses have been put forward. However, advances in the localization and treatment of these syndromes have evolved and aim at early identification particularly as the number of these syndromes is expected to rise. The development of well-designed prospective multicentre trials remains a priority in the field in order to fully characterise these syndromes and provide evidence-based diagnostic and therapeutic protocols. For extended coverage of this and related topics, please see our FREE on-line web- text www.endotext.org.

View Article
February 2017
2 Reads

PCOS remains a diagnosis of exclusion: a concise review of key endocrinopathies to exclude.

Clin Endocrinol (Oxf) 2017 Jan 11;86(1):1-6. Epub 2016 Oct 11.

Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals of Coventry and Warwickshire NHS Trust, Coventry, United Kingdom.

View Article
January 2017
5 Reads
3.46 Impact Factor

Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours.

Endocr Relat Cancer 2016 09 26;23(9):R423-36. Epub 2016 Jul 26.

Oxford Center for DiabetesEndocrinology and Metabolism, University of Oxford, Oxford, UK.

View Article
September 2016
6 Reads
4 PubMed Central Citations(source)
4.80 Impact Factor

Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance.

Clin Med (Lond) 2016 Jun;16(3):262-6

Institute of Reproductive and Developmental Biology, Imperial College, London, UK.

View Article
June 2016
5 Reads
3 PubMed Central Citations(source)
1.68 Impact Factor

Short-Chain Fatty Acid Acetate Stimulates Adipogenesis and Mitochondrial Biogenesis via GPR43 in Brown Adipocytes.

Endocrinology 2016 05 18;157(5):1881-94. Epub 2016 Mar 18.

Department of Translational and Experimental Medicine (J.H., B.K.T., G.K.D., G.T., V.P., M.K., J.C., H.S.R.), Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, United Kingdom; Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (I.K., B.K.T., G.K.D., H.S.R.) and Arden Tissue Bank (S.J.), Department of Pathology, University Hospitals Coventry and Warwickshire National Health Service Trust, Coventry CV2 2DX, United Kingdom; Birmingham Heartlands and Solihull Hospitals (B.K.T.), Heart of England National Health Service Foundation, National Health Service Trust, Birmingham B9 5SS, United Kingdom; Translational Research Institute (M.R.), Hamad Medical Corporation, 3050 Doha, Qatar; Jining Medical University (J.C.), 273100 Jining, People's Republic of China; and Aston Medical Research Institute (I.K., H.S.R.), Aston Medical School, Aston University, Birmingham B4 7ET, United Kingdom.

View Article
May 2016
5 Reads
9 PubMed Central Citations(source)
4.50 Impact Factor

Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study.

BMJ Open 2016 05 4;6(5):e010765. Epub 2016 May 4.

The ARDEN NET Centre, European Neuroendocrine Tumour Society (ENETS) Centre of Excellence (CoE), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK Division of Translational & Systems Medicine, Warwick Medical School, University of Warwick, Coventry, UK Coventry University, Centre for Applied Biological and Exercise Sciences, Coventry, UK.

View Article
May 2016
9 Reads
2.06 Impact Factor

Severe paraneoplastic hypoglycemia secondary to a gastrointestinal stromal tumour masquerading as a stroke.

Endocrinol Diabetes Metab Case Rep 2015 21;2015:150062. Epub 2015 Sep 21.

Warwick Institute for the Study of Endocrinology Diabetes and Metabolism (WISDEM Centre), The Arden NET Centre, University Hospitals of Coventry and Warwickshire, UHCW NHS Trust, ENETS CoE , Coventry , UK.

View Article
November 2015
38 Reads
1 PubMed Central Citation(source)

Plerixafor added to G-CSF-supported paclitaxel-ifosfamide-cisplatin salvage chemotherapy enhances mobilization of adequate numbers of hematopoietic stem cells for subsequent autografting in hard-to-mobilize patients with relapsed/refractory germ-cell tumors: a single-center experience.

Anticancer Drugs 2014 Aug;25(7):841-7

aDepartment of Medicine, Second Division of Medical Oncology and Hematopoietic Cell Transplant Program bDepartment of Transfusion Medicine and Cell Processing Laboratory, 'Metaxa' Cancer Hospital, Piraeus, Greece.

View Article
August 2014
12 Reads
1 PubMed Central Citation(source)
1.89 Impact Factor
Top co-authors
Harpal S Randeva
Harpal S Randeva

Warwick Medical School

14
Gregory Kaltsas
Gregory Kaltsas

National and Kapodistrian University of Athens

11
Martin O Weickert
Martin O Weickert

Warwickshire Institute for the Study of Diabetes

5
Thomas M Barber
Thomas M Barber

Churchill Hospital

4
Alexander D Miras
Alexander D Miras

Imperial College London

4
Dimitris K Grammatopoulos
Dimitris K Grammatopoulos

Warwick Medical School

3
Ashley Grossman
Ashley Grossman

Churchill Hospital

3
John G Hattersley
John G Hattersley

University Hospitals Coventry and Warwickshire NHS Trust

3
Ioannis Kyrou
Ioannis Kyrou

School of Health Science and Education

3
Christos Kosmas
Christos Kosmas

Metaxa Cancer Hospital

3